Search Results

Soliris: Eculizumab.

• Source: Formulary. 2007, Vol. 42, Issue 4, pages. 2

Record details

New biologic: Soliris.

Subjects: DRUG approval; CLINICAL drug trials; DRUG efficacy

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p215-216. 2p.

Record details

First-time generic approvals.

Subjects: LISTS; GENERIC drugs; DRUG approvalUNITED States

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p216-216. 1/6p.

Record details

New indication: Humira.

Subjects: DRUG approval; CLINICAL drug trials; DRUG efficacy

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p216-217. 2p.

Record details

Pipeline preview.

Subjects: LISTS; CANGENE Corp.; NOVARTIS AG

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p214-214. 2p.

Record details

New molecular entities: Tykerb.

Subjects: DRUG approval; CLINICAL drug trials; DRUG efficacy

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p214-215. 2p.

Record details

FDA Drug Approvals. FDA actions in brief.

Subjects: DRUGS

• Source: Formulary. Oct2011, Vol. 46 Issue 10, p401-401. 1/4p.

Record details

Specialty pharmacy's role in REMS, FDA's new drug safety program.

• Authors : Russek SB (AUTHOR)

• Source: Formulary. Oct2009, Vol. 44 Issue 10, p300-308. 6p.

Record details

New Indications.

Subjects: CLINICAL indications; DRUGS; PHARMACEUTICAL arithmetic

• Source: Formulary. Jan2004, Vol. 39 Issue 1, p6-8. 3p.

Record details

FDA Drug Approvals.

Subjects: DRUG legalization; NOVARTIS AG; BOEHRINGER Ingelheim GmbHUNITED States

• Source: Formulary. Dec2006, Vol. 41 Issue 12, p618-622. 3p.

Record details